| Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment SB Sartori, N Whittle, A Hetzenauer, N Singewald Neuropharmacology 62 (1), 304-312, 2012 | 293 | 2012 |
| Expression and 1, 4-dihydropyridine-binding properties of brain L-type calcium channel isoforms MJ Sinnegger-Brauns, IG Huber, A Koschak, C Wild, GJ Obermair, ... Molecular pharmacology 75 (2), 407-414, 2009 | 244 | 2009 |
| Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders SB Sartori, N Singewald Pharmacology & therapeutics 204, 107402, 2019 | 237 | 2019 |
| Magnesium-deficient diet alters depression-and anxiety-related behavior in mice—influence of desipramine and Hypericum perforatum extract N Singewald, C Sinner, A Hetzenauer, SB Sartori, H Murck Neuropharmacology 47 (8), 1189-1197, 2004 | 217 | 2004 |
| The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression RO Tasan, NK Nguyen, S Weger, SB Sartori, N Singewald, R Heilbronn, ... Journal of Neuroscience 30 (18), 6282-6290, 2010 | 169 | 2010 |
| Functional properties of a newly identified C-terminal splice variant of Cav1. 3 L-type Ca2+ channels G Bock, M Gebhart, A Scharinger, W Jangsangthong, P Busquet, ... Journal of Biological Chemistry 286 (49), 42736-42748, 2011 | 161 | 2011 |
| Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development N Whittle, SB Sartori, M Dierssen, G Lubec, N Singewald Pediatrics 120 (6), e1465-e1471, 2007 | 152 | 2007 |
| Tachykinin receptors as therapeutic targets in stress-related disorders K Ebner, SB Sartori, N Singewald Current pharmaceutical design 15 (14), 1647-1674, 2009 | 148 | 2009 |
| New paradigms for treatment‐resistant depression C Zarate, RS Duman, G Liu, S Sartori, J Quiroz, H Murck Annals of the New York Academy of sciences 1292 (1), 21-31, 2013 | 143 | 2013 |
| The clinical implications of mouse models of enhanced anxiety SB Sartori, R Landgraf, N Singewald Future neurology 6 (4), 531-571, 2011 | 121 | 2011 |
| Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression‐like behaviour: effects of chronic paroxetine treatment ME Keck, SB Sartori, T Welt, MB Müller, F Ohl, F Holsboer, R Landgraf, ... Journal of neurochemistry 92 (5), 1170-1179, 2005 | 114 | 2005 |
| Altered GABA transmission in a mouse model of increased trait anxiety RO Tasan, A Bukovac, YN Peterschmitt, SB Sartori, R Landgraf, ... Neuroscience 183, 71-80, 2011 | 112 | 2011 |
| Anxiety-rather than depression-like behavior is associated with adult neurogenesis in a female mouse model of higher trait anxiety-and comorbid depression-like behavior A Sah, C Schmuckermair, SB Sartori, S Gaburro, M Kandasamy, ... Translational psychiatry 2 (10), e171-e171, 2012 | 79 | 2012 |
| Behavioral and neurobiological effects of deep brain stimulation in a mouse model of high anxiety-and depression-like behavior C Schmuckermair, S Gaburro, A Sah, R Landgraf, SB Sartori, ... Neuropsychopharmacology 38 (7), 1234-1244, 2013 | 76 | 2013 |
| Changes in brain protein expression are linked to magnesium restriction-induced depression-like behavior N Whittle, L Li, WQ Chen, JW Yang, SB Sartori, G Lubec, N Singewald Amino Acids 40, 1231-1248, 2011 | 71 | 2011 |
| Cav1. 4 IT mouse as model for vision impairment in human congenital stationary night blindness type 2 D Knoflach, V Kerov, SB Sartori, GJ Obermair, C Schmuckermair, X Liu, ... Channels 7 (6), 503-513, 2013 | 65 | 2013 |
| Neuroinflammatory alterations in trait anxiety: modulatory effects of minocycline S Rooney, A Sah, MS Unger, M Kharitonova, SB Sartori, C Schwarzer, ... Translational Psychiatry 10 (1), 256, 2020 | 62 | 2020 |
| Enhanced fear expression in a psychopathological mouse model of trait anxiety: pharmacological interventions SB Sartori, M Hauschild, M Bunck, S Gaburro, R Landgraf, N Singewald PLoS One 6 (2), e16849, 2011 | 61 | 2011 |
| Selective breeding for high anxiety introduces a synonymous SNP that increases neuropeptide S receptor activity DA Slattery, RR Naik, T Grund, YC Yen, SB Sartori, A Füchsl, BC Finger, ... Journal of Neuroscience 35 (11), 4599-4613, 2015 | 58 | 2015 |
| Neural substrates for the distinct effects of presynaptic group III metabotropic glutamate receptors on extinction of contextual fear conditioning in mice A Dobi, SB Sartori, D Busti, H Van der Putten, N Singewald, R Shigemoto, ... Neuropharmacology 66, 274-289, 2013 | 51 | 2013 |